News
FDA Approves Endo International's Three-Time Rejected Testosterone Drug
Endo International Plc announced Thursday that the U.S. health regulators approved its thrice-rejected testosterone replacement therapy, Reuters reported.
Stanford University Strips MBA From Insider Trading Figure
College Board's New SAT Changes Meant to Simplify College Admissions Test
Cost of College Directing More Freshmen's Choice School Than Ever Before
Rare Skin Infection Spreading Through NYC Fish Markets
New Dinosaur Discovered May Be Europe's Largest Land Predator
Young Women Use Tanning Beds despite Health Risks, Study
Hangovers Have No Effect on Alcoholics, Study
By Staff ReporterVaccinated Women Less likely to Develop Cervical Cancer, Study
By Staff ReporterJupiter Moon: NASA Plans Ambitious Mission To Europa
By Jaleesa BaulkmanChildren With ADHD More Likely To Become Obese By Adolescence
By Staff ReporterPenn State To Hold Auction Of Intellectual Property Licenses
By Jaleesa BaulkmanSea Level Rise Threatens Cultural Landmarks
By Jaleesa BaulkmanThe Problem With Fraternities: 4 Ways Schools Can Stop the Harmful Behavior
By Russell WesterholmWHO Says Sugar Intake Should Be Halved
By Jaleesa Baulkman
